View source for 18392493. LUTEINIZING HORMONE-RELEASING HORMONE RECEPTOR (LHRH-R) CONJUGATES AND USES THEREOF simplified abstract (PURDUE RESEARCH FOUNDATION)

=LUTEINIZING HORMONE-RELEASING HORMONE RECEPTOR (LHRH-R) CONJUGATES AND USES THEREOF=


==Organization Name==

[[:Category:PURDUE RESEARCH FOUNDATION|PURDUE RESEARCH FOUNDATION]]


[[Category:PURDUE RESEARCH FOUNDATION]]

==Inventor(s)==

[[:Category:Philip Stewart Low of West Lafayette IN (US)|Philip Stewart Low of West Lafayette IN (US)]][[Category:Philip Stewart Low of West Lafayette IN (US)]]

[[:Category:Jyoti Roy of West Lafayette IN (US)|Jyoti Roy of West Lafayette IN (US)]][[Category:Jyoti Roy of West Lafayette IN (US)]]

==LUTEINIZING HORMONE-RELEASING HORMONE RECEPTOR (LHRH-R) CONJUGATES AND USES THEREOF - A simplified explanation of the abstract==


This abstract first appeared for US patent application 18392493 titled 'LUTEINIZING HORMONE-RELEASING HORMONE RECEPTOR (LHRH-R) CONJUGATES AND USES THEREOF

==Simplified Explanation==

The present teachings involve conjugates and methods for imaging a tumor microenvironment and treating LHRH-R expressing cancer in a patient, as well as methods of making conjugates with an LHRH-R antagonist.

* Conjugates and methods for imaging a tumor microenvironment in a patient
* Conjugates and methods for treating LHRH-R expressing cancer in a patient
* Method of making conjugates comprising an LHRH-R antagonist

== Potential Applications ==
This technology could be applied in the fields of oncology, radiology, and drug development.

== Problems Solved ==
This technology helps in accurately imaging tumor microenvironments and treating LHRH-R expressing cancer, leading to more targeted and effective therapies.

== Benefits ==
The benefits of this technology include improved diagnosis and treatment of cancer, potentially leading to better patient outcomes and reduced side effects.

== Potential Commercial Applications ==
Potential commercial applications of this technology could include the development of new imaging agents and targeted cancer therapies.

== Possible Prior Art ==
Prior art may include existing methods for imaging tumor microenvironments and treating LHRH-R expressing cancer, as well as known LHRH-R antagonists.

=== Unanswered Questions ===

=== How does this technology compare to existing imaging methods for tumor microenvironments? ===
This article does not provide a direct comparison to existing imaging methods for tumor microenvironments. Further research or clinical trials may be needed to determine the superiority of this technology.

=== What are the potential side effects of using LHRH-R antagonists in cancer treatment? ===
The article does not address the potential side effects of using LHRH-R antagonists in cancer treatment. Additional studies or trials may be required to assess the safety profile of this approach.


==Original Abstract Submitted==

The present teachings relate generally to conjugates and methods for imaging a tumor microenvironment in a patient, and to conjugates and methods for treating LHRH-R expressing cancer in a patient. The present teachings relate generally to method of making conjugates comprising an LHRH-R antagonist.



[[Category:A61K47/54]]
[[Category:A61K38/09]]
[[Category:A61K45/06]]
[[Category:A61K47/65]]
[[Category:A61K49/00]]
[[Category:A61P35/00]]